Annotation Detail

Information
Associated Genes
TOP1
Associated Variants
TOP1 AMPLIFICATION ( ENST00000361337.3 )
TOP1 AMPLIFICATION ( ENST00000361337.3 )
Associated Disease
colorectal cancer
Source Database
CIViC Evidence
Description
FFPE tumor samples from 78 patients with colorectal cancer, who had received irinotecan monotherapy were analyzed with a FISH dual-probe. TOP1 gain was nonsignificantly associated with objective response to irinotecan Odds ratio (OR): 1.62; p = 0.07.
Variant Origin
somatic
Variant Origin
Somatic
Evidence URL
https://civic.genome.wustl.edu/links/evidence_items/888
Gene URL
https://civic.genome.wustl.edu/links/genes/5845
Variant URL
https://civic.genome.wustl.edu/links/variants/371
Rating
1
Evidence Type
Predictive
Disease
Colorectal Cancer
Evidence Direction
Supports
Drug
Irinotecan
Evidence Level
B
Clinical Significance
Sensitivity/Response
Pubmed
24256029
Drugs
Drug NameSensitivitySupported
IrinotecanSensitivitytrue